<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36959633</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2490</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>23</Day></PubDate></JournalIssue><Title>BMC urology</Title><ISOAbbreviation>BMC Urol</ISOAbbreviation></Journal><ArticleTitle>Case report: disease mechanisms and medical management of calcium nephrolithiasis in rheumatologic diseases.</ArticleTitle><Pagination><StartPage>42</StartPage><MedlinePgn>42</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">42</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12894-023-01203-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Nephrolithiasis as a feature of rheumatologic diseases is under recognized. Understanding presenting features, diagnostic testing is crucial to proper management.</AbstractText><AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">A 32&#xa0;year old woman with a history of recurrent complicated nephrolithiasis presented to a rheumatologist for a several month history of fatigue, dry eyes, dry mouth, arthralgias. She had a positive double-stranded DNA, positive SSA and SSB antibodies. She was diagnosed with Systemic Lupus erythematosus (SLE) and Sjogren's syndrome and was started on mycophenalate mofetil. Of relevance was a visit to her local emergency room 4&#xa0;years earlier with profound weakness with unexplained marked hypokalemia and a non-anion gap metabolic acidosis. Approximately one year after that episode she developed flank pain and nephrocalcinosis. She had multiple issues over the ensuing years with stones and infections on both sides. Interventions included extracorporeal shockwave lithotripsy as well as open lithotomy and eventual auto-transplantation of left kidney for recurrent ureteric stenosis. 24&#xa0;h stone profile revealed marked hypocitraturia, normal urine calcium, normal urine oxalate and uric acid. She was treated with potassium citrate. Mycophenolate was eventually stopped due to recurrent urinary tract infections and she was started on Belimumab. Because of recurrent SLE flares, treatment was changed to Rituximab (every 6&#xa0;months) with clinical and serologic improvement. Her kidney stone frequency gradually improved and no further interventions needed although she continued to require citrate repletion for hypocitraturia.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Nephrolithiasis can be a prominent and even presenting feature in Sjogrens syndrome as well as other rheumatologic diseases. Prompt recognition and understanding disease mechanisms is important for best therapeutic interventions for kidney stone prevention as well as treatment of underlying bone mineral disease.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Osman</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Medicine, Allegheny Health Network, 320 East North Ave, Pittsburgh, PA, 15212, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manzi</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Allegheny Health Network, 320 East North Ave, Pittsburgh, PA, 15212, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wasko</LastName><ForeName>Mary Chester</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Medicine, Allegheny Health Network, 320 East North Ave, Pittsburgh, PA, 15212, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Barbara A</ForeName><Initials>BA</Initials><Identifier Source="ORCID">0000-0002-6696-1424</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Allegheny Health Network, 320 East North Ave, Pittsburgh, PA, 15212, USA. Barbara.clark@ahn.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Urol</MedlineTA><NlmUniqueID>100968571</NlmUniqueID><ISSNLinking>1471-2490</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical><Chemical><RegistryNumber>2968PHW8QP</RegistryNumber><NameOfSubstance UI="D019343">Citric Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053040" MajorTopicYN="Y">Nephrolithiasis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007669" MajorTopicYN="Y">Kidney Calculi</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019343" MajorTopicYN="N">Citric Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Calcium metabolism</Keyword><Keyword MajorTopicYN="N">Case report</Keyword><Keyword MajorTopicYN="N">Crohn&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Kidney stones</Keyword><Keyword MajorTopicYN="N">Nephrocalcinosis</Keyword><Keyword MajorTopicYN="N">Nephrolithiasis</Keyword><Keyword MajorTopicYN="N">Osteoporosis</Keyword><Keyword MajorTopicYN="N">Renal tubular acidosis</Keyword><Keyword MajorTopicYN="N">Sarcoidosis</Keyword><Keyword MajorTopicYN="N">Sjogrens syndrome</Keyword><Keyword MajorTopicYN="N">Vitamin D</Keyword></KeywordList><CoiStatement>There are no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>24</Day><Hour>0</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36959633</ArticleId><ArticleId IdType="pmc">PMC10035194</ArticleId><ArticleId IdType="doi">10.1186/s12894-023-01203-y</ArticleId><ArticleId IdType="pii">10.1186/s12894-023-01203-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ramos-Casals M, Tzioufas AG, Font J. Primary Sj&#xf6;gren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis. 2005;64:347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1755414</ArticleId><ArticleId IdType="pubmed">15498797</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271.</Citation><ArticleIdList><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariette X, Criswell LA. Primary sjogrens syndrome. NEJM. 2018;387(10):931&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pubmed">29514034</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Magder L. Classification criteria for systemic lupus erythematosus: a review. Lupus. 2004;13:829.</Citation><ArticleIdList><ArticleId IdType="pubmed">15580978</ArticleId></ArticleIdList></Reference><Reference><Citation>Weening JJ, D'agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65(2):521&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">14717922</ArticleId></ArticleIdList></Reference><Reference><Citation>Maripuri S, Grande JP, Osborn TG, Fervenza FC, Matteson EL, Donadio JV, Hogan MC. Renal involvement in primary sjogren&#x2019;s syndrome: a clinicopathologic study. Clin J Am Soc Nephrol. 2009;4(9):1423&#x2013;1431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2736689</ArticleId><ArticleId IdType="pubmed">19679669</ArticleId></ArticleIdList></Reference><Reference><Citation>Toosi TD, Naderi N, Movassaghi S, Seradj MH, Khalvat A, Shahbazi F. Secondary sjogren's syndrome presenting with hypokalemic periodic paralysis&#xa0;.Oxford Medical Case Reports 2014; 1(8): 135&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4369992</ArticleId><ArticleId IdType="pubmed">25988057</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowd JE, Lipsky PE. Sjogren&#x2019;s syndrome presenting as hypokalemic periodic paralysis. Arthritis Rheum. 1993;36(12):1735&#x2013;1738.</Citation><ArticleIdList><ArticleId IdType="pubmed">8250993</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza-Alpirez A, Arana-Guajardo AC,&#xa0;Esquivel-Valerio A,&#xa0;Villarreal-Alarc&#xf3;n MA, Galarza-Delgado DA. Hypokalemic paralysis due to primary sj&#xf6;gren syndrome: case report and review of the literature case reports in rheumatology. Volume 2017; 2017: 7509238</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5556603</ArticleId><ArticleId IdType="pubmed">28835864</ArticleId></ArticleIdList></Reference><Reference><Citation>Shioji R, Furuama T, Onodera S, Saito H, Ito H, Sasai Y. Sjogrens syndrome and renal tubular acidosis. Am J Med. 1970;48(4):456&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">5444301</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastani B, Haragism L, Gluck S, Siamopoulos KC. Lack of H-ATPase in distal nephron causing hypokalemic distal RTA in a patient with SjogrenSyndrome. Nephrol Dial Transplant. 1995;10(6):908&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">7566631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawashia M, Amano T, Morita Y, Yamanura M, Makino H. Hypokalemic paralysis and osteomalacia secondary to renal tubular acidosis in a case with primary sjogren syndrome. Mod Rheumatol. 2006;16(1):48&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">16622725</ArticleId></ArticleIdList></Reference><Reference><Citation>Goroshi M, Khare S, Jamale T, Shah NS. Primary sjogren's syndrome presenting as hypokalemic paralysis: a case series. J Postgraduate Med. 2017;63(2):128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5414423</ArticleId><ArticleId IdType="pubmed">27853045</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakhaee K, Maalouf NM, Sinnott B. Kidney stones 2012: pathogenesis, diagnosis, and management. J Clin Endocrinol Metab. 2012;97(6):1847&#x2013;1860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3387413</ArticleId><ArticleId IdType="pubmed">22466339</ArticleId></ArticleIdList></Reference><Reference><Citation>Worcester EM, Coe FL. Nephrolithiasis. Prim Care. 2008;35(2):369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2518455</ArticleId><ArticleId IdType="pubmed">18486720</ArticleId></ArticleIdList></Reference><Reference><Citation>Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005;115(10):2598&#x2013;2608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1236703</ArticleId><ArticleId IdType="pubmed">16200192</ArticleId></ArticleIdList></Reference><Reference><Citation>Coe FL, Parks JH, Evan AP, Worcester E. Pathogenesis and treatment of nephrolithiasis. In: Alpern RJ, Hebert SC, editors. Seldin and Giebisch's The Kidney. 4. Academic Press; 2007. pp. 1945&#x2013;1977.</Citation></Reference><Reference><Citation>Kumar V, Lieske JC. Protein regulation of intrarenal crystallization. Curr Opin Nephrol Hypertens. 2006;15:374&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pubmed">16775451</ArticleId></ArticleIdList></Reference><Reference><Citation>Evan AP, Lingeman J, Coe F, Shao Y, Miller N, Matlaga B, et al. Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int. 2007;71(8):795&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">17264873</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherrard DJ. Metabolic causes of nephrolithiasis. Western J Med. 1983;138(4):541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1010739</ArticleId><ArticleId IdType="pubmed">6688144</ArticleId></ArticleIdList></Reference><Reference><Citation>Moe OW, Bonny O. Genetic hypercalciuria. J Ame Soc Nephrol. 2005;16(3):729&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pubmed">15689405</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayer JA. Progress in understanding the genetics of calcium containing nephrolithiasis. JASN. 2017;28(3):748&#x2013;759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5328168</ArticleId><ArticleId IdType="pubmed">27932479</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzato G, Fraioli P, Montemurro L. Nephrolithiasis as a presenting feature of chronic sarcoidosis. Thorax. 1995;50(5):555&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1021229</ArticleId><ArticleId IdType="pubmed">7597671</ArticleId></ArticleIdList></Reference><Reference><Citation>Tebben PJ, Singh RJ, Kumar R. Vitamin D mediated hypercalcemia: mechanisms, diagnosis and management. Endocrine Rev. 2016;37(5):521&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5045493</ArticleId><ArticleId IdType="pubmed">27588937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kino-Ohsaki J, Nishimari I, Morita M, Okazaki K, Yamamoto Y, Onishi S, Hollingsworth MA. Serum autoantibodies to carbonic anhydrase I and II in patient with idiopathic chronic pancreatitis and Sjogren syndrome. Gastroenterology. 1996;110(5):1579&#x2013;1586.</Citation><ArticleIdList><ArticleId IdType="pubmed">8613065</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhya P, Danda P, Rajanatham S, Thomas N. Sjogrens, RTA and oteomalacia, an Asian Indian series. Open Rheumatol J. 2014;8:103&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4286932</ArticleId><ArticleId IdType="pubmed">25584094</ArticleId></ArticleIdList></Reference><Reference><Citation>Arman F, Shakeri H, Nobakht N, Rastogi A, Kamgar M. A case of kidney I involvement in primary sjogren syndrome. Am J Case Rep. 2017;18:622&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5467668</ArticleId><ArticleId IdType="pubmed">28577018</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujisawa,Y. SuzukT. Zoshima,S, Hara S, Ito K, Mizushima I,,Fujii H, Kawano M. High frequency of kidney stones and or nephrocalcinosis in primary Sjogren syndrome might accelerate chronic renal dysfunction due to tubular interstitial disease. And eles of the rheumatic diseases, 2020; 79: FR 1066</Citation></Reference><Reference><Citation>Bossini N, Savoldi S, Franceschini F, Mombelloni S, Baronio M, Cavazzana I, Viola BF, Valzorio B, Mazzucchelli C, Cattaneo R, Scolari F. Clinical and morphological features of kidney involvement in primary Sj&#xf6;gren's syndrome. Nephrol Dialysis Transp. 2001;16(12):2328&#x2013;2336.</Citation><ArticleIdList><ArticleId IdType="pubmed">11733624</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilcher G, Schwarz C, Hermann J. Successful treatment of renal tubular acidosis and recurrent secondary struvite kidney stones with rituximab in a patient with primary Sj&#xf6;gren&#x2019;s syndrome. Rheumatology. 2017;56(3):498&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pubmed">28031439</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolova M, Ivanov G, Makova G, Iliev A, Hristova M, Georgieva I, Gencheva Z, Nikolova R, G. Sheinkova, Vlaho Y+, Alexiev E,, Petkov K, Boneva T, Liubomirova M, Krasteva R, Bogo B, Todorov T, Elenkova E. Sjogren&#x2019;s syndrome and the kidney. Archiv Immunol Allergy 2018; 1: 20&#x2013;24</Citation></Reference><Reference><Citation>Basok AB, Haviv YS, Rogachev B, Vorobiov M. Renal tubular acidosis type 1 with prominent hypokalemia and nephrolithiasis as a presentation of Sjogren&#x2019;s /systemic lupus erythematosus disease. Case Rep Nephrology Dial. 2021;11:247&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8436655</ArticleId><ArticleId IdType="pubmed">34595212</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbengue M, Ouanekpone C, Diagne S, Niang A. From hypokalemic crisis to sjogren&#x2019;s syndrome: a case report and literature review. Case Reports Nephrol Dialysis. 2021;11(2):147&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8255739</ArticleId><ArticleId IdType="pubmed">34250032</ArticleId></ArticleIdList></Reference><Reference><Citation>Linan LMJ, Montero SAR, Marenco de la Fuente JL. Nephrocalcinosis at patient with rheumatoid arthritis and secondary Sjogren&#x2019;s syndrome. J Reumae 2017; 2: 005</Citation><ArticleIdList><ArticleId IdType="pubmed">28359765</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin W, Shye M. 35-year-old female with Sjogren syndrome and chronic kidney disease. Proceedings UCLA health 2020; 24</Citation></Reference><Reference><Citation>Aguilera S, Lopez R, Valdivieso A. Distal renal tubular acidosis and nephrolithiasis in 3 cases of primary Sj&#xf6;gren syndrome. Rev Med Chil. 1996;124(12):1467&#x2013;1475.</Citation><ArticleIdList><ArticleId IdType="pubmed">9334481</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanuto AC, Bueno T, Delfino VD, Mocelin AJ. Nephrocalcinosis in a patient with Sj&#xf6;gren's syndrome/systemic lupus erythematosus. Rev Assoc Med Bras. 2012;58:279&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">22735216</ArticleId></ArticleIdList></Reference><Reference><Citation>Moutsopoulus HM, Cledes J, Skopouli M, Eliasf M, Youinou P. Nephrocalcinosis in Sjogren syndrome: a late manifestation of renal tubular acidosis. J Intern Med; 1991, 230(2): 187&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">1865172</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajput R, Sehgal A, Jain D, Sen R, Saini O. Nephrocalcinosis: a rare presenting manifestation of primary Sj&#xf6;gren&#x2019;s syndrome. Modern Rheumatol. 2012;22(3):479&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">21984129</ArticleId></ArticleIdList></Reference><Reference><Citation>Dworsky Z, Bakhoun C, Chiraseveenuprapund P, Khare M, Nourbakhsh ND. Sjogren&#x2019;s syndrome presenting with distal renal tubular acidosis in adolescent. Biomed J Sci Techn Res. 2019;20(2):14928&#x2013;14932.</Citation></Reference><Reference><Citation>Aasar&#xf8;d K, Haga HJ, Berg KJ, Hammerstr&#xf8;m J, J&#xf8;rstad S. Renal involvement in primary Sj&#xf6;gren's syndrome. QJM. 2000;93(5):297&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">10825406</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjaj-Hassouni N, Guedira N, Lazrak N, Harsouni F, Filali A, Mansouri A, Balafrej L. Osteomalacia as presenting manifestation of Sjogren Syndrome. Rev Rheum Engl Ed. 1995;62:529&#x2013;532.</Citation><ArticleIdList><ArticleId IdType="pubmed">8574618</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherie E, Ben Hassine L, Kaoueche Z, Khalfallah N. Osteomalacia as inaugural manifestation of sjogrens syndrome. BMJ Case Rep. 2013;2013:br2013201052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3822150</ArticleId><ArticleId IdType="pubmed">24108773</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiger NS, Bushinsky DA. The relation between bone and stone formation. Calcif Tissue Int. 2013;93(40):374&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3625692</ArticleId><ArticleId IdType="pubmed">23247537</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger NS, Frick KK, Bushinsky DA. Mechanism of acid-induced bone resorption. Curr Opinion Nephrol Hypertension. 2004;13(4):423&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">15199293</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrabal-Polo MA, Cano-Garcia Mdel C, Canales BK, Arabal- MM. calcium nephrolithiasis in bone demineralization: pathophysiology diagnosis and management. Current opinion Urology. 2014;24(6):633&#x2013;638.</Citation><ArticleIdList><ArticleId IdType="pubmed">25188231</ArticleId></ArticleIdList></Reference><Reference><Citation>Jir&#xe1;&#x10d;kov&#xe1; J, Hy&#x161;pler R, Alkanderi S, Pavl&#xed;kov&#xe1; L, Palicka V, Sayer JA. Novel CYP24A1 mutation in a young male patient with nephrolithiasis: case report. Kidney Blood Press Res. 2019;44(4):870&#x2013;877.</Citation><ArticleIdList><ArticleId IdType="pubmed">31288237</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayers J, Hynes AM, Sricvstava S, Dowen F, Quinton R, Datta HR, et al. Successful treatment of hypercalcemia associated with a CYP24A1 mutation with fluconazole. Clin Kidney J. 2015;8(4):453&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4515887</ArticleId><ArticleId IdType="pubmed">26251716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ketha H, Singh RJ, Grebe SK, Bergstralh EJ, Rule AD, Lieske JC. Kumar R. Altered calcium and vitamin D homeostasis in first-time calcium kidney stone-formers. PLos ONE (2015); 10(9):e0137350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4558059</ArticleId><ArticleId IdType="pubmed">26332888</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein LN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal disease in inflammatory bowel disease: a population based study. Am J Gastroenterol. 2001;96(4):1116&#x2013;1122.</Citation><ArticleIdList><ArticleId IdType="pubmed">11316157</ArticleId></ArticleIdList></Reference><Reference><Citation>Worcester EM. Stones from bowel disease. Endocrinol Metab Clin North AM. 2002;31(4):979&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pubmed">12474641</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi L, Gaiani F, Bizzarri B, Minelli R, Cortegosov P, Leandro G, DiMario F, Luigi de Angelis G, Roberto C. Renal lithiasis and inflammatory bowel disease, an update on pediatric population. Acta Biomed 2018; 89 (9) 76&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6502195</ArticleId><ArticleId IdType="pubmed">30561398</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinchieri A, Lizzano R, Catelnuvo C, Zanetti G, Pisani E. Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease. Arch Ital Urol Androl. 2002;74(2):61&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">12161938</ArticleId></ArticleIdList></Reference><Reference><Citation>McConnell N, Campbell S, Gillander I, Rolton H, Danesh B. Risk factors for development of renal stones in inflammatory bowel disease. BJU Int. 2002;89(9):835&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pubmed">12010224</ArticleId></ArticleIdList></Reference><Reference><Citation>Prezioso D, Strazzalo P, Lotti T, Bianchi G. CLU working group. Dietary treatment of urinary risk factors for renal stones. Arch Ital Urol. 2015;87(2):105&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">26150027</ArticleId></ArticleIdList></Reference><Reference><Citation>Gul Z, Monga M. Medical and dietary therapy for kidney stone prevention. Korean J Urol. 2014;55(12):775&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4265710</ArticleId><ArticleId IdType="pubmed">25512810</ArticleId></ArticleIdList></Reference><Reference><Citation>Curhan GC, Willett W, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328(12):833&#x2013;838.</Citation><ArticleIdList><ArticleId IdType="pubmed">8441427</ArticleId></ArticleIdList></Reference><Reference><Citation>Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Int Med. 1997;126(7):497&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">9092314</ArticleId></ArticleIdList></Reference><Reference><Citation>Curhan GC, Willett WV, Speizer FE, Stampfer MJ. Intake of Vitamin B6 and C and the risk of kidney stone in women. J Am Soc Nephrol. 1999;10(4):840&#x2013;845.</Citation><ArticleIdList><ArticleId IdType="pubmed">10203369</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi G, Guisti A, Piol G, Barone A, Palummeri E, Girasole G. bisphosphonates in management of idiopathic hypercalciuria associated with osteoporosis. Therapeutic Adv Musculoskeletal Disease. 2010;2(1):29&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3383465</ArticleId><ArticleId IdType="pubmed">22870435</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick KK, Krieger NS, Bushinsky DA. Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat. Curr Opinion Nephrology Hyper. 2015;24(4):336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4495578</ArticleId><ArticleId IdType="pubmed">26050120</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosman F. Anabolic and antiresorptive therapy for osteoporosis: combination and sequential approaches. Curr Osteoporsis Rep. 2014;12(4):385&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">25341476</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>